4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-011769
Director acquired 4,165 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Duncan Barbara Gayle Director | 2025-05-01 | Grant or award | +4,165 | 19,919 | D | ||
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2025-05-01 | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | D | ||
Loading xslF345X05/form4-05022025_080549.xml…